Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 12/20 | 0.37 |
| ▸ | STING1 | Q86WV6 | 4/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17363657 | 1.00 | DNPH1 (0.37) | DNPH1STING1RXFP1 | |
| SCHEMBL16871738 | 1.00 | DNPH1 (0.37) | DNPH1STING1RXFP1 | |
| SCHEMBL17363656 | 1.00 | DNPH1 (0.37) | DNPH1STING1RXFP1 | |
| SCHEMBL16871895 | 0.92 | DNPH1 (0.44) | DNPH1STING1 | |
| SCHEMBL17363663 | 0.92 | DNPH1 (0.44) | DNPH1STING1 | |
| SCHEMBL18486268 | 0.89 | DNPH1 (0.37) | DNPH1STING1 | |
| SCHEMBL16871833 | 0.89 | PDE7A (0.35) | DNPH1STING1 | |
| SCHEMBL17363612 | 0.89 | PDE7A (0.35) | DNPH1STING1 | |
| SCHEMBL18486390 | 0.88 | DNPH1 (0.49) | DNPH1STING1 | |
| SCHEMBL16871801 | 0.88 | DNPH1 (0.45) | DNPH1STING1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10378011-B2 | Oligonucleotide | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2019-08-13 | — | — | US | disclosed |
| US-20150376611-A1 | OLIGONUCLEOTIDE | KYOWA KIRIN CO., LTD. (JP) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10378011-B2 | Oligonucleotide | HNRNPA3, AGO2, RBM3 | DNPH1 4323/4885STING1 1227/4885RXFP1 901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.